PHILADELPHIA--(BUSINESS WIRE)--SwanBio Therapeutics, a gene therapy company focused on developing treatments for patients with genetically defined neurological conditions, today announced new ...
PHILADELPHIA--(BUSINESS WIRE)--SwanBio Therapeutics, a gene therapy company advancing AAV-based therapies for the treatment of devastating, inherited neurological conditions, today presented updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results